Fermenta Biotech Q1FY26: Net Profit INR 21.6 cr, Revenue INR 145 cr, EBITDA INR 37 cr

Fermenta Biotech Limited, a leading manufacturer of premium-grade APIs, intermediates, and nutritional premixes, announced its unaudited financial results for Q1FY26. The company reported a consolidated net profit of INR 21.6 crore, a significant improvement from the INR 5.9 crore loss in the same period last year. The consolidated revenue stood at INR 145 crore, up 79% YoY, and EBITDA was INR 37 crore, up 922% YoY. The nutrition volume grew by 83% over QIFY25 and 8% over Q4FY25, while the animal nutrition volume grew by 45% over QIFY25 but decreased by 17% over Q4FY25. The company also announced the incorporation of a wholly owned subsidiary focused on environmental solutions and an MoU with NIFTEM-T for a Centre of Excellence for Food Fortification.